Previous Article | Next Article 
Journal of Virology, October 1998, p. 8158-8165, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Functional Analysis of the Human Cytomegalovirus
US28 Gene by Insertion Mutagenesis with the Green Fluorescent
Protein Gene
Jeffrey
Vieira,1,2,*
Thomas J.
Schall,3
Lawrence
Corey,1,2 and
Adam P.
Geballe4
Department of Laboratory Medicine, University
of Washington, Seattle, Washington 981951;
Program in Infectious Diseases, Fred Hutchinson Cancer Research
Center, Seattle, Washington 981042;
ChemoCentryx, Mountain View, California
940433; and
Divisions of Molecular
Medicine and Clinical Research, Fred Hutchinson Cancer Research
Center, Seattle, Washington 981094
Received 16 January 1998/Accepted 10 July 1998
 |
ABSTRACT |
The protein encoded by the US28 gene of human cytomegalovirus
(HCMV) has homology to G protein-coupled receptors (GCR). Previous studies demonstrated that recombinant US28 protein can bind the
class of chemokines (K. Neote, D. DiGregorio, J. Y. Mak, R. Horuk,
and T. J. Schall, Cell 72:415-425, 1993) and induce a rise in
intracellular calcium after the binding of chemokines (J. L. Gao
and P. M. Murphy, J. Biol. Chem. 269:28539-28542, 1994). In order to investigate the function of the US28 protein in virus-infected cells, a recombinant HCMV (HV5.8) was constructed, with the US28 open
reading frame disrupted by the insertion of the Escherichia coli
gpt gene and the gene for the green fluorescent protein. The US28
gene is not required for growth in human fibroblasts (HF). HF infected
with wild-type HCMV bound RANTES at 24 h postinfection and
demonstrated an intracellular calcium flux induced by RANTES. In cells
infected with HV5.8, RANTES did not bind or induce a calcium flux,
demonstrating that US28 is responsible for the
-chemokine binding
and induced calcium signaling in HCMV-infected cells. The ability of
the US28 gene to bind chemokines was shown to cause a significant
reduction in the concentration of RANTES in the medium of infected
cells. Northern analysis of RNA from infected cells showed that US28 is
an early gene, while US27 (another GCR) is a late gene.
 |
INTRODUCTION |
Open reading frames (ORF) with
homology to cellular seven transmembrane spanning receptors have been
identified in the genomes of both beta and gamma herpesviruses
(15, 37). Many cellular seven transmembrane spanning
receptors have been shown to be G protein-coupled receptors (GCR) and
comprise a superfamily of genes encoding the receptors for a variety of
biological compounds, including neurotransmitters, hormones, odorants,
and chemotactic agents. GCR link the binding of an extracellular ligand
to processes within the cell by their activation of associated G
proteins. G proteins can activate serine/threonine kinases,
phosphatidylinositol 3-kinase, phospholipases, or Ras (9).
These proteins, in turn, can stimulate mitogen-activated protein kinase
or generate second messenger molecules, such as diacylglycerol and
inositol triphosphate, resulting in the activation of protein kinase C
and increases in intracellular Ca2+ levels (9).
Ultimately, these processes result in the amplification of the initial
signal transduced by the ligand-GCR interaction into complex cellular
processes such as chemotaxis.
GCR are receptors for chemokines, derived from chemotactic cytokine, a
multigene family of 70- to 90-amino-acid soluble proteins that are
excreted from a variety of cell types and play important roles in
leukocyte trafficking and immune regulation (7). Two classes
of these structurally similar proteins are defined by the first two of
four conserved cysteines. In the
class (e.g., interleukin-8
[IL-8], MGSA, and GCP-2) the first two cysteines are separated by an
intervening residue (C-X-C), while in the
class (e.g., RANTES,
MIP-1
, MIP-1
, and MCP-1) they are adjacent (C-C). In general, the
-chemokines attract primarily neutrophils, while
-chemokines can
have activity on monocytes, lymphocytes, eosinophils, and basophils
(46).
The human cytomegalovirus (HCMV) US28 ORF shows approximately 33%
homology to the cellular
-chemokine receptor CCR-1 (35). Conserved features of viral and cellular proteins include the putative
seven-membrane spanning regions and cysteines implicated in disulfide
bond formation. The sequence homology between US28 and cellular GCR led
to the identification of
-chemokines as the ligand for the viral
receptor. Recombinant HCMV US28 protein expressed in 293 cells was
shown to bind
-chemokines (35), and as with the binding
of chemokines by their cellular receptors, the binding of ligand by
recombinant US28 expressed in K562 cells led to an increase in
intracellular calcium (21).
During an acute infection, HCMV can be found in the blood as well as in
numerous tissues, with the lungs, kidneys, salivary gland, and liver
being commonly involved. HCMV has been identified in a wide variety of
cells both in culture and in patients' tissue, including epithelial
cells, endothelial cells, fibroblasts, monocytes/macrophages, and
lymphocytes (33, 47, 52). Because HCMV can infect cell types
that respond to chemokines and cell types that produce chemokines, the
viral GCR may mimic the functions of cellular GCR, but the role of the
expression of a viral GCR in viral biology and the cell type in which
it is important are not known.
While researchers examined US28 function with recombinant protein in
previous studies (21, 36), we have investigated the functions of the US28 gene expressed from the viral genome. We have
constructed a recombinant HCMV with the US28 ORF disrupted by the genes
for the green fluorescent protein (GFP) and guanine phosphoribosyl
transferase (GPT) and have demonstrated that US28 is responsible for
the functions of a GCR in HCMV-infected cells.
 |
MATERIALS AND METHODS |
Cells and viruses.
Human foreskin fibroblasts (HF) were
grown in Dulbecco's modified Eagle's medium (Gibco Laboratories)
supplemented with 10% Nu serum (Collaborative Research, Inc.), 0.1 mg
of streptomycin, 100 U of penicillin, and 2 mM L-glutamine
in a humidified 5% CO2 37°C incubator. HCMV (Towne) was
used for all experiments.
Construction of recombinant virus.
The 6-kb BamHI
Q fragment (216298 to 222296 of the published sequence
[14]) of AD169 was cloned into the BamHI
site of pOK7 to generate pQ62. A deletion was then generated between
the BspHI (219198) and the StuI (219627) sites
contained within the BamHI Q fragment to create pQ63. This
construct, pQ63, was digested with BclI and a 2.5-kb
BamHI fragment consisting of the Escherichia coli
gpt gene expressed by the herpes simplex virus (HSV) tk promoter and the GFP gene under the control of the rat
-actin promoter was
inserted into the BclI site (position 219666) to create
pQ64. For the transfection of HF, pQ64 was digested with
BamHI, extracted with phenol-CHCl3 and CHCl3, ethanol
precipitated, and dried. The DNA was resuspended in STE (5 mM NaCl, 5 mM Tris-HCl [pH 7.5], 1 mM EDTA) at a concentration of 1 to 2 mg/ml,
and 20 µg was used per electroporation. For electroporation, HF were
trypsinized, mixed with an equal volume of medium, pelleted at 500 × g for 5 min, and resuspended in electroporation buffer (a
1:3 mixture of OptiMEM I [Gibco] and cytomix [54]
[120 mM KCl, 0.15 mM CaCl2, 10 mM
K2HPO4-KH2PO4 [pH
7.6], 5 mM MgCl2]). In 0.4 ml of electroporation buffer
2 × 106 to 5 × 106 HF cells plus
DNA were electroporated with a BTX ECM 600 instrument set at 285 V and
1,075 µF in a 4-mm cuvette at room temperature. Cells were plated
following electroporation and infected with HCMV at a multiplicity of
infection (MOI) of 2 to 5 at 18 to 24 h postelectroporation.
Progeny virus from these cultures, harvested 5 days postinfection
(dpi), was used to infect fresh HF and cultured in medium containing 25 µg of xanthine per ml and 15 µg of mycophenolic acid per ml. Virus
was harvested 2 days post-100% cytopathic effect, and selection with
mycophenolic acid was repeated. Progeny virus from the second
mycophenolic acid selection was then used to plaque purify recombinant
virus by twofold-limiting dilution in 96-well plates. Recombinant virus
was identified as green fluorescent plaque under 450- to 490-nm UV
illumination.
Two additional viruses, HV5.6 and HV5.7, that have the same US28
deletion and use the same insertion site as HV5.8 have been constructed. HV5.6 was constructed with pQ63 with the insertion of the
BamHI LacZ-GPT cassette of pON855 (55) at the
BclI site. This virus was generated and selected for with
mycophenolic acid and xanthine as described above for HV5.8.
Recombinant virus was plaque purified with X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) overlay as described previously (49). HV5.7, which has only the insertion of the 240-bp simian virus 40 (SV40) polyadenylation signal (position 2533 to 2770) at the BclI site, was
generated from HV5.6 with back selection against the gpt
gene with the drug 6-thioguanine by growing HV5.6 in human Lesch-Nyhan
(hypoxanthine-GPT deficient) skin fibroblasts (25). The
generation of HV5.7 is possible because the LacZ-GPT cassette of pON855
is flanked by direct repeats of the SV40 polyadenylation signals and
recombination can occur between these two repeated sequences, deleting
the LacZ and GPT genes, making the virus resistant to 6-thioguanine,
and leaving a single SV40 polyadenylation signal as the insert
(41, 56). Genome structure of these recombinant HCMV was
confirmed by viral DNA analysis as described previously for HV5.8 (data not shown).
Radioligand binding and displacement.
Displaceable binding
of 125I-labeled chemokine was performed on HF at various
times after infection. Cells (2 × 106 cells per ml)
were incubated with 0.5 nM radiolabeled ligands and varying
concentrations of unlabeled ligands at 4°C for 2 h. The
incubation was terminated by removing aliquots from the cell suspension
and separating cells from buffer by centrifugation through a
silicon-paraffin oil mixture (43). Nonspecific binding was
determined in the presence of 1 mM unlabeled ligand. Individual assay
determinations, representative of at least three separate experiments,
are plotted. Iodine-labeled chemokines were obtained from Dupont/NEN
(Boston, Mass.), and unlabeled chemokines were obtained from R&D
Systems (Minneapolis, Minn.). Both homologous and heterologous
chemokine displacements were measured. Experiments were carried out
with two independently isolated recombinant viruses.
Cytoplasmic calcium measurements.
HF were loaded with 2 mM
indo-1/AM (Molecular Probes, Inc., Eugene, Oreg.) in complete growth
medium at 20°C for 45 min. Cells were then washed, resuspended in
Na-Hanks balanced salt solution (2 mM CaCl2, 145 mM NaCl, 5 mM KCl, 1 mM MgCl2, 5 mM glucose, 20 mM HEPES, pH 7.3)
containing 1% bovine serum albumin and maintained at 20°C for up to
2 h. Approximately 5 × 105 cells were then
suspended in 2 ml of Na-Hanks balanced salt solution and maintained at
37°C in a constantly stirred acrylic cuvette. Fluorescence
measurements to determine the increase in cytosolic-free Ca2+ concentration ([Ca2+]i) were done with a
Photon Technologies Inc. spectrofluorimeter with an excitation
wavelength of 350 nm (4-nm bandwidth) and dual simultaneous monitoring
of emission at 405 and 485 nm (10-nm bandwidth). The ratio of emission
at 405 and 485 nm was measured at a rate of 2 Hz. Experiments were
carried out with two independently isolated recombinant viruses.
RNA analysis.
HF in 60-mm-diameter dishes were infected at
an MOI of 5 PFU/cell. When used, ganciclovir (30 µm) was added to the
culture medium 1 h before infection. At various times
postinfection, whole-cell RNA was harvested (16) and
analyzed by formaldehyde agarose gel electrophoresis and Northern
hybridization (22) with a 32P-labeled probe. The
US27 probe included the sequence from 217761 to 219008 of the AD169
sequence, and the US28 probe was composed of a PCR-generated clone of
the US28 ORF (36).
Determination of RANTES concentration in culture
supernatants.
HF seeded in 15.5-mm wells were infected at an MOI
of 3, with Towne, HV5.8, UV-inactivated Towne, or heat-inactivated
Towne (60°C, 20 min) or left uninfected. At the end of 1 h of
absorption, the inoculum was removed and the cells washed with
phosphate-buffered saline, and 0.3 ml of medium was added to each well.
For each experimental interval, the medium was removed from the culture and 0.3 ml of fresh medium was added. The collected medium was centrifuged for 5 min at 1,500 × g, and the
supernatant was removed to a fresh tube and stored at
70°C until
analyzed. The RANTES concentration was determined with an enzyme-linked
immunosorbent assay kit for RANTES (R&D Systems) following the
manufacturer's instructions.
 |
RESULTS |
Construction and analysis of recombinant HCMV.
The steps for
the construction of HV5.8, a recombinant HCMV (Towne) with the
disruption of the US28 ORF by a deletion and the insertion of a GPT-GFP
cassette, are diagrammed in Fig. 1. The
construct used to construct HV5.8, pQ64, consisted of the BamHI Q fragment (position 216298 to 222296 of the Ad169
sequence) with a deletion of the first 40% of the US28 ORF between
positions 219200 (BspHI) and 219629 (StuI). A
GPT-GFP cassette was inserted at position 219666 (BclI)
within the US28 ORF. The GPT-GFP construct (Fig. 1) contains the
E. coli gpt gene expressed by the HSV thymidine kinase
promoter (55) and the GFP gene (13) expressed
from the rat
-actin promoter (38). The transcripts of
both genes are terminated by early polyadenylation signals of the
bidirectional SV40 polyadenylation signals (12), which can
provide polyadenylation functions for viral genes upstream of the
insertion site (55). HV5.8 was generated by pQ64-transfected
HF, which were subsequently infected with HCMV (Towne). Progeny virus
was grown under selection for the gpt gene for two cycles,
and recombinant virus containing the GFP was plaque purified by the
identification of green fluorescent plaques under 450- to 490-nm
illumination.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 1.
Structure of HV5.8, HV5.7, and the GPT-GFP insert.
Schematic diagram of the HCMV genome with the expansion of the 6-kb
BamHI fragment containing the US28 gene used to construct
recombinant virus. The BspHI-to-StuI deletion
removed 430 bp of the US28 ORF. The BclI site is the
insertion point for the GPT-GFP cassette in HV5.8 or the SV40
polyadenylation segment (nucleotides 2533 to 2774 [20]) in HV5.7. The components of the GPT-GFP cassette
are (starting at the left) SV40 sequence [poly(A)], nucleotides 2533 to 2774 (20); the E. coli guanine-xanthine
phosphoribosyl transferase gene (GPT), nucleotides 667 to 121 (40); the HSV thymidine kinase promoter (TK), nucleotides
47925 to 48108 (31); SV40 sequence, nucleotides 128 to 37 (20); the rat -actin promoter ( -act), nucleotides 124 to 262 (38); the human T-cell leukemia virus R region,
nucleotides 96 to 270 (42); the A. victoria GFP
gene, nucleotides 26 to 742 (39); SV40 sequence [poly(A)],
nucleotides 2774 to 2533 (20).
|
|
Two additional viruses, with the same deletion of US28 as HV5.8, but
with different inserts at the
BclI site (219666), have
also
been constructed. HV5.6 has the LacZ-GPT insert from pON855
(
55) at the
BclI site, and HV5.7 (Fig.
1) has
only the 240-bp
SV40 polyadenylation sequence inserted and therefore
does not
express any heterologous proteins. HV5.7 was generated from
HV5.6
by back selection against the
gpt gene with the drug
6-thioguanine
(
25).
Viral DNA from HV5.8 was isolated to examine the structure of the viral
genome and to confirm the absence of wild-type HCMV.
Viral DNAs of
HV5.8 and HCMV (Towne) were digested with
BamHI
or
HindIII and separated by agarose gel electrophoresis.
The DNA
was analyzed by ethidium bromide staining (Fig.
2A) and by hybridization
with a
32P-labeled DNA probe containing US27 and US28 sequences
(Fig.
2B).
The comparison of HCMV and HV5.8 DNAs in the ethidium
bromide
gel showed no alterations outside of the US28-containing
fragments.
The hybridization analysis showed that the 6-kb
BamHI and the
14-kb
HindIII fragments (which
contain US28) detected by the probe
in HCMV (Towne) were absent from
HV5.8 and that fragments 2 kb
larger than the HCMV (Towne) fragments
were present, as expected.

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of the genomic structure of HV5.8. Viral DNA
was prepared from HCMV (Towne) and HV5.8, digested with
BamHI or HindIII, and electrophoresed on a
0.6% agarose gel. (A) Ethidium-bromide-stained viral DNA. Molecular
size standards in kilobase pairs are indicated on the left. (B)
Autoradiograph resulting from the hybridization analysis of the viral
DNAs with the US27-US28 32P-labeled probe depicted in Fig.
7.
|
|
The recombinant virus HV5.8 carries the gene for the GFP from the
jellyfish
Aequorea victoria (
39) expressed from
the rat

-actin promoter. The use of the GFP as a marker for
recombinant
virus allows the visualization of infected cells by
fluorescent
microscopy (Fig.
3). In
addition, the presence of the GFP makes
possible the sorting of
infected cells by fluorescence-activated
cell sorting, sorted cells
remained viable, and recombinant virus
could be recovered (data not
shown).

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 3.
Visualization of HCMV plaque on HF. (A) Photomicrogragh
of viral plaque under normal illumination. (B) HV5.8 plaque on HF
photographed under 450- to 490-nm UV illumination with a Nikon
microscope at 200× magnification.
|
|
The growth kinetics of HV5.8 and HCMV (Towne) were compared (Fig.
4). A four- to fivefold reduction in peak
titers was seen
in HV5.8. This result was not likely due to secondary
mutations
outside of the US28 region, because three independently
derived
recombinant viruses showed the same phenotype (data not shown).
Whether this phenotype is due to the loss of the US28 ORF, the
loss of
an ORF of 290 codons that overlaps approximately 75% of
the US28 ORF
and is also disrupted in HV5.8, or an effect of the
insert has not been
resolved.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Growth kinetics of HCMV (Towne) and HV5.8. HF were
infected at an MOI of 0.05 with either wild-type HMCV or HV5.8,
harvested at the time indicated, and frozen at 70°C. Samples were
thawed and sonicated at the time of titering. Initial inocula took
place on day 0, and the detection limit was 10 PFU/ml.
|
|
Chemokine binding.
To determine if HCMV-infected cells would
show specific chemokine binding, experiments with labeled chemokines as
ligands were performed. HF infected with HCMV 24 and 48 h
postinfection were incubated with 125I-RANTES and
increasing amounts of unlabeled RANTES. The amount of labeled RANTES
bound to the cells was determined, showing that 125I-RANTES
bound to HCMV-infected cells, and this binding was prevented by
competition with unlabeled RANTES (Fig.
5A and B). HF and HF infected with HV5.8
or HV5.7 at 24 or 48 h postinfection did not demonstrate
125I-RANTES binding (Fig. 5A and B). This binding was
specific for
-chemokines in that MCP-1, like unlabeled RANTES, could
compete with labeled RANTES binding, but IL-8 did not (Fig. 5C). In
addition, cells 4 h postinfection with wild-type HCMV or HV5.8 did
not show increased RANTES binding compared to uninfected cells (data
not shown). The lack of chemokine binding by cells infected by both HV5.8 and HV5.7 supports the finding that US28 is the protein responsible for
-chemokine binding by infected cells.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Binding of 125I-labeled RANTES by infected
cells. (A) Uninfected HF and HF infected for 24 h with wild-type
HCMV, HV5.7, or HV5.8 were incubated with 125I-labeled
RANTES in the presence of increasing amounts of unlabeled RANTES, and
the amount of labeled RANTES was determined. (B) The displacement of
125I-labeled RANTES by unlabeled RANTES on cells infected
with wild-type HCMV, HV5.7, or HV5.8 at 48 h postinfection. (C)
The displacement of 125I-labeled RANTES from HCMV-infected
cells 48 h postinfection by either MCP-1 or IL-8, at a
concentration of 100 nM. cpm, counts per minute.
|
|
Calcium flux.
To test if the US28 ORF, expressed from the
viral genome, was responsible for the induction of a calcium flux, the
intracellular calcium level in HF infected with HCMV (Towne) or HV5.8
was monitored upon the addition of various chemokines. Changes in the
intracellular calcium levels were monitored by loading infected cells
with the fluorescent calcium indicator indo-1/AM and measuring the
change in fluorescence, with an increase in relative fluorescence
illustrating an increase in intracellular calcium. No change in
intracellular calcium levels was seen upon the addition of RANTES in
uninfected HF or in cells infected for 4 h with HCMV, while HF
infected for 24 or 48 h demonstrated an increase in calcium with
the addition of RANTES (Fig. 6A). In
experiments with HV5.8, no calcium flux was detected with the addition
of RANTES at any time point (Fig. 6B).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 6.
Intracellular calcium flux in HF infected by HCMV and
HV5.8. At the times indicated after infection, cells were loaded with
the calcium indicator, indo-1/AM, and monitored spectrofluorometrically
during the addition of the indicated chemokine. (A) HCMV-infected cells
at 4, 24, and 48 h postinfection and uninfected HF, treated with 1 µM RANTES. (B) HF and HF infected with HV5.8 at 24 and 48 h
postinfection with the addition of 1 µM RANTES. (C) HF infected with
HCMV at 24 h postinfection. The top trace shows cells treated with
1 µM MIP-1 followed by 1 µM RANTES, and the bottom trace shows
cells treated with 1 µM IL-8 and then 1 µM RANTES.
|
|
It has been demonstrated that a recombinant US28 gene expressed in cell
lines can elicit a calcium response to

-chemokines
other than RANTES
but not to

-chemokines (
21). HF infected
with HCMV were
tested for the generation of a calcium flux in
response to MIP-1

(a

-chemokine) and IL-8 (an

-chemokine) (Fig.
6C). A response to
MIP-1

was detected, and a subsequent addition
of RANTES did not give
a second calcium flux. The addition of
IL-8 to HCMV-infected cells did
not elicit a calcium flux, but
the subsequent addition of RANTES did
generate a response. In
addition, an increase in intracellular calcium
was detected in
response to the

-chemokines, MCP-1 and MIP-1

, but
to a lesser
degree than to RANTES or MIP-1

(data not shown).
Northern analysis of US27 and US28.
The binding and calcium
flux data indicated that the US28 gene was expressed by 24 h
postinfection. To confirm that this was true, the temporal expression
of US28 and that of US27 were determined by Northern analysis of total
RNA isolated from HF at 4, 24 and 48 h postinfection with HCMV
(Towne) and at 48 h postinfection in the presence of ganciclovir.
Figure 7 shows the Northern analysis of
these samples with US27, or US28, derived probes. The US27 and US28
genes are transcribed in the same direction and terminate at a common
polyadenylation signal at the end of US28, which results in a 2.9-kb
US27 transcript and a 1.3-kb US28 transcript (57). No signal
was detected in uninfected HF or at 4 h postinfection. A 1.3-kb
transcript, corresponding to US28, was detected at 24 and 48 h
postinfection, and a 2.9-kb transcript, from US27, was detected only at
48 h postinfection. In the presence of ganciclovir at 48 h
postinfection only the 1.3-kb RNA was detected, identifying US28 as an
early gene and US27 as a late gene.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 7.
Northern blot analysis of the US27 and US28 transcripts.
Whole-cell RNA was isolated from mock-infected HF, HF infected at 4, 24, and 48 h postinfection, and HF infected at 48 h
postinfection in the presence of ganciclovir. RNA was electrophoresed
on a 1% agarose-1.2 M formaldehyde gel and blotted onto
nitrocellulose. The autoradiograph resulting from the hybridization
analysis of the RNA with either a US27-derived or a US28-derived
32P-labeled probe is shown. Lane 1, mock infected; lane 2, 4 h postinfection; lane 3, 24 h postinfection; lane 4, 48 h postinfection; lane 5, 48 h postinfection with
ganciclovir. The positions of the 1.3 US28 and the 2.9 US27 transcripts
as well as the positions of 28S and 18S rRNA are indicated.
|
|
US28 moderation of RANTES concentration in CMV-infected
cultures.
Human fibroblasts can be induced to produce RANTES by
inoculation with tumor necrosis factor alpha (34) or CMV
(32). The effect of US28 on the level of RANTES present in
medium of infected cultures was determined by assaying the RANTES
concentration in culture supernatants from HF, and HF infected with
Towne, HV5.8, UV-inactivated virus, or heat-inactivated virus, at the
time intervals indicated in Fig. 8.
Uninfected HF and those infected with heat-inactivated virus produced
minimally detectable levels of RANTES at all time points, while HF
infected with Towne, HV5.8, and UV-inactivated virus showed a
significant increase in RANTES by 8 h postinfection, with
increased amounts at the 8- to 16-h interval. The level of RANTES in
cultures infected with Towne rapidly declined after 16 h
postinfection until 36 h postinfection, when levels were similar
to those for uninfected cells. HV5.8-infected cells maintained a high
level of RANTES through 36 h postinfection, but a reduction did
occur 2 and 3 dpi. HF infected with UV-inactivated virus maintained elevated levels of RANTES expression at all time intervals.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 8.
RANTES concentration in culture supernatants collected
at the time intervals indicated from cultures of HF infected with
Towne, HV5.8, Towne inactivated with UV (UV), Towne inactivated with
heat (heat), and uninfected HF (uninf). Results plotted are the
averages of four experiments.
|
|
 |
DISCUSSION |
It was previously demonstrated that cell lines expressing
recombinant US28 could bind
-chemokines and show a calcium flux in
the presence of chemokine ligands (21, 35). In this study, we demonstrate that human fibroblasts infected with HCMV gain the
functions consistent with those of a GCR that recognizes
-chemokines as a ligand. HCMV-infected cells bind RANTES, a
-chemokine, and respond to the addition of
-chemokines with the induction of an
intracellular calcium flux. Cells infected with a virus lacking US28
did not show these functions, demonstrating that the functions of a GCR
for
-chemokines seen in infected cells are due to US28 and not to
other viral genes or to an induced cellular gene.
It was found that US28 is an early gene, while US27 is a late gene. The
expression of the US28 transcript temporally corresponded to the
functions of a GCR for
-chemokines identified in HCMV-infected cells. The expression of the US28 mRNA at 24 h postinfection
contrasts with earlier work with AD169 indicating that both US28 and
US27 were late genes (57). Possible reasons for the
different results could be viral strain differences, the use of
ganciclovir instead of phosphonoformic acid (PFA), or that in the
previous work RNA was examined at only a single time point, 7 dpi, and
the extended PFA treatment may have had nonspecific effects. A recent
study in which PCR was used for the detection of RNA also suggested that the US28 gene is an early gene (32), but their methods could not distinguish between US27 or US28 as an early gene. It has
been postulated that the HCMV GCR may be constituents of the virion and
may account for the changes in intracellular calcium levels seen in
cells shortly after infection (57). While the UL33 protein
was shown to be a component of the virion (30), we did not
detect the activity of the US28 protein in the first few hours of
infection, indicating that the US28 protein is not a virion protein or
that it is present at too low a level to be detected by our methods.
Human fibroblasts are capable of producing RANTES (34), and
inoculation of HF with CMV can induce RANTES expression
(32). We found that the US28 gene has a profound effect on
the level of RANTES present in the medium of infected cells. There was
a rapid increase in RANTES present in culture supernatants from cells
inoculated with Towne, HV5.8, or UV-inactivated virus, whereas a steep
decline in RANTES was seen in Towne-infected cultures starting at the
16- to 24-h postinfection interval; the level in HV5.8 infected
cultures remained elevated. However, a reduction of RANTES in
supernatants of cultures infected with HV5.8 was seen at 2 and 3 dpi,
compared to cultures infected with UV-inactivated virus, suggesting
that factors other than US28 can contribute to lowered chemokine
levels. While this result would support a role for US28 in reducing the
immune response to sites of infection, it remains to be determined
whether this is indicative of a true immune evasion function for US28
or simply an in vitro effect of the expression of a functional
chemokine receptor by the virus.
Genes encoding GCR are a common theme in the genomes of gamma and beta
herpesviruses. The UL33, UL78, US27, and US28 ORFs of HCMV (15,
24), the U12 and U51 ORFs of human herpesvirus 6 (HHV-6)
(24), ORF 74 of HHV-8 (45), and ECRF3 of
herpesvirus saimiri (1) all have homology to cellular GCR.
Epstein-Barr virus, a gamma herpesvirus without a viral GCR, induces
the expression of two cellular GCR, EBI-1 and EBI-2 (8).
EBI-1 is also induced by HHV-6 and -7 (26). The ubiquitous
presence of GCR with beta and gamma herpesviruses suggests an important
role for these proteins in viral pathogenesis, but this role has not
yet been elucidated. Three possible functions have been suggested for
viral GCR: (i) immune evasion, (ii) cell activation, and (iii)
promotion of cell migration and virus dissemination. Our data showing
that HCMV-infected cells at early times after infection gain the
function of a GCR for
-chemokines can lend support to any of these
roles postulated for viral GCR.
Viral genes involved in immune evasion that mimic cellular functions
have been identified previously. Poxviruses express soluble proteins
that bind IL-1
and gamma interferon (3, 51, 53), and the
use of recombinant virus in animal models has shown that these proteins
can influence the host response (2, 3). It is possible that
the US28 protein sequesters chemokines, thereby reducing the host
immune response to sites of infection. The potential importance of
chemokines to the immune response is illustrated in transgenic mice
lacking the
-chemokine MIP-1
, in which a delayed clearance of
influenza virus was found (18). In support of its
functioning to adsorb chemokines, US28 was shown to have greater
binding affinity than CCR-1, one of the cellular receptors, for a
spectrum of
-chemokines (35, 45a). Our data demonstrating that the US28 gene can reduce the level of RANTES released by an
infected cell in vitro also support a possible role in immune evasion.
Although the US28 gene may function in immune evasion by binding
chemokines, the fact that the US28 protein transmits an intracellular
signal suggests that it also has other functions, since signal
transduction should not be required for sequestering chemokines alone.
The early kinetics of expression of US28 and the induction of processes
involved in cell activation shown by the US28 protein are consistent
with its having a role in activating a cell to allow or enhance viral
replication. While CMV has been shown to replicate in a number of cell
types that may express a chemokine receptor (10, 11, 19,
47), the superior binding of chemokines by the US28 GCR may be
important for the activation of an infected cell at a level of ligand
below that which activates uninfected cells. The US28 protein may also
lead to the activation of cells by chemokines that do not naturally
express a chemokine receptor.
Chemokines function as cell chemotactic agents in the induction of cell
adhesion to endothelium and the enhancement of cell migration across
the endothelium (6, 44). Thus, the US28 gene may function to
influence the migration of infected cells. The
-chemokines can act
as chemotactic agents for monocytes, T cells, and NK cells (4, 6,
29, 44), some of which can be infected by HCMV (10, 17, 19,
23, 27, 47, 48). The expression of the US28 protein would add to
infected cells a GCR with high affinity for a number of
-chemokines
(36). This receptor may therefore give infected cells an
improved or novel migratory ability and thereby contribute to virus
dissemination.
In the construction of the HCMV US28 mutant, the GFP was used as a
marker that allowed the identification of recombinant plaques under UV
illumination as well as the fluorescence-activated cell sorting of
infected cells and the recovery of virus. Since the recombinant GFP
gene, isolated from the jellyfish A. victoria (39), was first used as a genetic marker in
Caenorhabditis elegans (13), it has been used in
a variety of organisms, including yeast (5), mammalian cells
(50), and transgenic mice (28). GFP is a valuable
biological marker which allows a nonevasive detection that requires
only illumination by UV light to yield green fluorescence. While the
GFP is useful for the identification of recombinant virus, the greatest
utility of GFP-tagged viruses may be for the noninvasive identification
of infected cells. Future investigations on the functions of viral GCR
will likely involve the study of monocytes and other cell populations
in which only a subset of cells may be experimentally infected by CMV.
In such cell populations, the GFP can allow the specific observation of infected cells or the isolation of infected cells for use in subsequent experiments regarding the study of viral GCR.
 |
ACKNOWLEDGMENT |
This study was supported in part by NIH grant AI26672 (awarded to
A.P.G.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, Program in Infectious Diseases, 1124 Columbia St., Seattle, WA 98104. Phone: (206) 667-6795. Fax: (206) 667-4411. E-mail: vieiraj{at}u.washington.edu.
 |
REFERENCES |
| 1.
|
Ahuja, S. K., and P. M. Murphy.
1993.
Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri.
J. Biol. Chem.
268:20691-20694[Abstract/Free Full Text].
|
| 2.
|
Alcam'i, A., and G. L. Smith.
1996.
A mechanism for the inhibition of fever by a virus.
Proc. Natl. Acad. Sci. USA
93:11029-11034[Abstract/Free Full Text].
|
| 3.
|
Alcam'i, A., and G. L. Smith.
1992.
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.
Cell
71:153-167[Medline].
|
| 4.
|
Allavena, P.,
G. Bianchi,
D. Zhou,
J. van Damme,
P. J'Ilek,
S. Sozzani, and A. Mantovani.
1994.
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3.
Eur. J. Immunol.
24:3233-3236[Medline].
|
| 5.
|
Atkins, D., and J. G. Izant.
1995.
Expression and analysis of the green fluorescent protein gene in the fission yeast Schizosaccharomyces pombe.
Curr. Genet.
28:585-588[Medline].
|
| 6.
|
Audran, R.,
T. Lesimple,
M. Delamaire,
C. Picot,
J. Van Damme, and L. Toujas.
1996.
Adhesion molecule expression and response to chemotactic agents of human monocyte-derived macrophages.
Clin. Exp. Immunol.
103:155-160[Medline].
|
| 7.
|
Baggiolini, M. B.,
B. Dewald, and B. Moser.
1994.
IL-8 and related chemotactic cytokines CXC and CC chemokines.
Adv. Immunol.
55:97-149[Medline].
|
| 8.
|
Birkenbach, M.,
K. Josefsen,
R. Yalamanchili,
G. Lenoir, and E. Kieff.
1993.
Epstein-Barr virus-induced genes: first lymphocyte specific G protein-coupled peptide receptors.
J. Virol.
67:2209-2220[Abstract/Free Full Text].
|
| 9.
|
Bokoch, G. M.
1995.
Chemoattractant signaling and leukocyte activation.
Blood
86:1649-1660[Free Full Text].
|
| 10.
|
Braun, R. W., and H. C. Reiser.
1986.
Replication of human cytomegalovirus in human peripheral blood T cells.
J. Virol.
60:29-36[Abstract/Free Full Text].
|
| 11.
|
Brytting, M.,
M. Mousavi Jazi,
L. Bostrom,
M. Larsson,
J. Lunderberg,
P. Ljungman,
O. Ringd'en, and V. A. Sundqvist.
1995.
Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.
Transplantation
60:961-965[Medline].
|
| 12.
|
Carswell, S., and J. C. Alwine.
1989.
Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences.
Mol. Cell. Biol.
9:4248-4258[Abstract/Free Full Text].
|
| 13.
|
Chalfie, M.,
Y. Tu,
G. Euskirchen,
W. W. Ward, and D. C. Prasher.
1994.
Green fluorescent protein as a marker for gene expression.
Science
263:802-805[Abstract/Free Full Text].
|
| 14.
|
Chee, M. S.,
A. T. Bankier,
S. Beck,
R. Bohini,
C. M. Brown,
T. Cerny,
T. Horsnell,
C. A. Hutchinson III,
T. Kouzarides,
E. Martignetti,
E. Preddie,
S. C. Satchwell,
P. K. M. Weston, and B. G. Barrell.
1990.
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
Curr. Top. Microbiol. Immunol.
154:123-169.
|
| 15.
|
Chee, M. S.,
S. C. Satchwell,
E. Preddie,
P. K. M. Weston, and B. G. Barrell.
1990.
Human cytomegalovirus encodes three G protein-coupled receptor homologues.
Nature
344:774-777[Medline].
|
| 16.
|
Chomezynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 17.
|
Cinatl, J., Jr.,
J. U. Vogel,
J. Cinatl,
B. Weber,
H. Rabenau,
M. Novak,
B. Kornhuber, and H. W. Doerr.
1996.
Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line.
Int. J. Cancer
65:90-96[Medline].
|
| 18.
|
Cook, D. N.,
M. A. Beck,
T. M. Coffman,
S. L. Kirby,
J. F. Sheridan,
I. B. Pragnell, and O. Smithies.
1995.
Requirement of MIP-1 alpha for an inflammatory response to viral infection.
Science
269:1583-1585[Abstract/Free Full Text].
|
| 19.
|
Dankner, W. M.,
J. A. McCutchan,
D. D. Richman,
K. Hirata, and S. A. Spector.
1990.
Localization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.
J. Infect. Dis.
161:31-36[Medline].
|
| 20.
|
Fiers, W.,
R. Contreras,
G. Haegemann,
R. Rogiers,
A. Van de Voorde,
H. Van Heuverswyn,
J. Van Herreweghe,
G. Volckaert, and M. Ysebaert.
1978.
Complete nucleotide sequence of SV40 DNA.
Nature
273:113-120[Medline].
|
| 21.
|
Gao, J. L., and P. M. Murphy.
1994.
Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor.
J. Biol. Chem.
269:28539-28542[Abstract/Free Full Text].
|
| 22.
|
Geballe, A. P.,
F. S. Leach, and E. S. Mocarski.
1986.
Regulation of cytomegalovirus late gene expression: genes are controlled by posttranscriptional events.
J. Virol.
57:864-874[Abstract/Free Full Text].
|
| 23.
|
Gerna, G.,
D. Zipeto,
E. Percivalle,
M. Parea,
M. G. Revello,
R. Maccario,
G. Peri, and G. Milanesi.
1992.
Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients.
J. Infect. Dis.
166:1236-1244[Medline].
|
| 24.
|
Gompels, U. A.,
J. Nicholas,
G. Lawrence,
M. Jones,
B. J. Thomson,
M. E. Martin,
S. Efstathiou,
M. Craxton, and H. A. Macaulay.
1995.
The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution.
Virology
209:29-51[Medline].
|
| 25.
|
Greaves, R. F.,
J. M. Brown,
J. Vieira, and E. S. Mocarski.
1995.
Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene.
J. Gen. Virol.
76:2151-2160[Abstract/Free Full Text].
|
| 26.
|
Hasegawa, H.,
Y. Utsunomiya,
M. Yasukawa,
K. Yanagisawa, and S. Fujita.
1994.
Induction of G protein-coupled peptide receptor EBI 1 by human herpersvirus 6 and 7 infection in CD4+ T cells.
J. Virol.
68:5326-5329[Abstract/Free Full Text].
|
| 27.
|
Ibanez, C. E.,
R. Schrier,
P. Ghazal,
C. Wiley, and J. A. Nelson.
1991.
Human cytomegalovirus productively infects primary differentiated macrophages.
J. Virol.
65:6581-6588[Abstract/Free Full Text].
|
| 28.
|
Ikawa, M.,
K. Kominami,
Y. Yoshimura,
K. Tanaka,
Y. Nishimune, and M. Okabe.
1995.
A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP).
FEBS Lett.
375:125-128[Medline].
|
| 29.
|
Loetscher, P.,
M. Seitz,
I. Clark Lewis,
M. Baggiolini, and B. Moser.
1996.
Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release.
J. Immunol.
156:322-327[Abstract].
|
| 30.
|
Margulies, B. J.,
H. Browne, and W. Gibson.
1996.
Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles.
Virology
225:111-125[Medline].
|
| 31.
|
McGeoch, D. J.,
M. A. Dalrymple,
A. J. Davison,
A. Dolan,
M. C. Frame,
D. McNab,
L. J. Perry,
J. E. Scott, and P. Taylor.
1988.
The complete DNA sequence of the long unique region in the genome of the herpes somplex virus type 1.
J. Gen. Virol.
69:1531-1574[Abstract/Free Full Text].
|
| 32.
|
Michelson, S.,
P. Dal Monte,
D. Zipeto,
B. Bodaghi,
L. Laurent,
E. Oberlin,
F. Arenzana-Seisdedos,
J.-L. Virelizier, and M. P. Landini.
1997.
Modulation of RANTES production by human cytomegalovirus infection of fibroblasts.
J. Virol.
71:6495-6500[Abstract].
|
| 33.
|
Myerson, D.,
R. C. Hackman,
J. A. Nelson,
D. C. Ward, and J. K. McDougal.
1984.
Widespread presence of histologically occult cytomegalovirus.
Hum. Pathol.
15:430-439[Medline].
|
| 34.
|
Nelson, P. J.,
H. T. Kim,
W. C. Manning,
T. J. Goralski, and A. M. Krensky.
1993.
Genomic organization and transcriptional regulation of the RANTES chemokine gene.
J. Immunol.
151:2601-2612[Abstract].
|
| 35.
|
Neote, K.,
W. Darbonne,
J. Ogez,
R. Horuk, and T. J. Schall.
1993.
Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells.
J. Biol. Chem.
268:12247-12249[Abstract/Free Full Text].
|
| 36.
|
Neote, K.,
D. DiGregorio,
J. Y. Mak,
R. Horuk, and T. J. Schall.
1993.
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor.
Cell
72:415-425[Medline].
|
| 37.
|
Nicholas, J.,
K. R. Cameron, and R. W. Honess.
1992.
Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins.
Nature
355:362-365[Medline].
|
| 38.
|
Nudel, U.,
R. Zakut,
S. Neuman,
Z. Levy, and D. Yaffe.
1983.
The nucleotide sequence of the rat cytoplasmic -actin gene.
Nucleic Acids Res.
11:1759-1768[Abstract/Free Full Text].
|
| 39.
|
Prasher, D. C.,
C. K. Eckenrode,
W. W. Ward,
F. G. Prendergast, and M. J. Cormier.
1992.
Primary structure of the Aequorea victoria green fluorescent protein.
Gene
111:229-233[Medline].
|
| 40.
|
Pratt, D., and S. Subramani.
1983.
Nucleotide sequence of the Escherichia coli xanthine-guanine phosphoribosyl transferase gene.
Nucleic Acids Res.
11:8817-8823[Abstract/Free Full Text].
|
| 41.
| Pritchard, M., and E. S. Mocarski. Personal
communication.
|
| 42.
|
Retzel, E.,
A. Evanelista,
S. Maroushek,
H. Minnigan,
A. Larson,
A. T. Haase,
D. Gonzalez-Dunia,
D. McFarlin,
E. Mingiolo,
S. Jacabson,
M. Osame, and S. Sonoda.
1990.
Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis.
Microb. Pathog.
8:259-278[Medline].
|
| 43.
|
Robb, R. J.,
W. C. Greene, and C. M. Rusk.
1984.
Low and high affinity receptors for interleukin 2.
J. Exp. Med.
160:1126-1146[Abstract/Free Full Text].
|
| 44.
|
Roth, S. J.,
M. W. Carr, and T. A. Springer.
1995.
C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes.
Eur. J. Immunol.
25:3482-3488[Medline].
|
| 45.
|
Russo, J. J.,
R. A. Bohensky,
M.-C. Chien,
J. Chen,
M. Yan,
D. Maddalena,
J. P. Parry,
D. Peruzzi,
I. S. Edelman,
C. Yuan, and P. S. Moore.
1996.
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
Proc. Natl. Acad. Sci. USA
93:14862-14867[Abstract/Free Full Text].
|
| 45a.
| Schall, T. Unpublished observations.
|
| 46.
|
Schall, T. J., and K. B. Bacon.
1994.
Chemokines, leukocyte trafficking, and inflammation.
Curr. Opin. Immunol.
6:865-873[Medline].
|
| 47.
|
Schrier, R. D.,
J. A. Nelson, and M. B. Oldstone.
1985.
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection.
Science
230:1048-1051[Abstract/Free Full Text].
|
| 48.
|
Soderberg, C.,
S. Larsson,
S. Bergstedt Lindqvist, and E. Moller.
1993.
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.
J. Virol.
67:3166-3175[Abstract/Free Full Text].
|
| 49.
|
Spate, R. R., and E. S. Mocarski.
1987.
Insertion and deletion mutagenesis of the human cytomegalovirus genome.
Proc. Natl. Acad. Sci. USA
84:7213-7217[Abstract/Free Full Text].
|
| 50.
|
Stauber, R.,
G. A. Gaitanaris, and G. N. Pavlakis.
1995.
Analysis of trafficking of Rev and transdominant Rev proteins in living cells using green fluorescent protein fusions: transdominant Rev blocks the export of Rev from the nucleus to the cytoplasm.
Virology
213:439-449[Medline].
|
| 51.
|
Symons, J. A.,
A. Alcam'i, and G. L. Smith.
1995.
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity.
Cell
81:551-560[Medline].
|
| 52.
|
Taylor-Wiedeman, J.,
J. G. Sissons,
L. K. Borysiewicz, and J. H. Sinclair.
1991.
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.
J. Gen. Virol.
72:2059-2064[Abstract/Free Full Text].
|
| 53.
|
Upton, C.,
K. Mossman, and G. McFadden.
1992.
Encoding of a homolog of the IFN-gamma receptor by myxoma virus.
Science
258:1369-1372[Abstract/Free Full Text].
|
| 54.
|
van der Hoff, M. J. B.,
A. F. M. Moorman, and W. H. Lamers.
1992.
Electorporation in `intracellular' buffer increases cell survival.
Nucleic Acids Res.
20:2902[Free Full Text].
|
| 55.
|
Vieira, J.,
H. E. Farrell,
W. D. Rawlinson, and E. S. Mocarski.
1994.
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette.
J. Virol.
68:4837-4846[Abstract/Free Full Text].
|
| 56.
| Vieira, J. Unpublished data.
|
| 57.
|
Welch, A. R.,
L. M. McGregor, and W. Gibson.
1991.
Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed.
J. Virol.
65:3915-3918[Abstract/Free Full Text].
|
Journal of Virology, October 1998, p. 8158-8165, Vol. 72, No. 10
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stropes, M. P., Schneider, O. D., Zagorski, W. A., Miller, J. L. C., Miller, W. E.
(2009). The Carboxy-Terminal Tail of Human Cytomegalovirus (HCMV) US28 Regulates both Chemokine-Independent and Chemokine-Dependent Signaling in HCMV-Infected Cells. J. Virol.
83: 10016-10027
[Abstract]
[Full Text]
-
Cardin, R. D., Schaefer, G. C., Allen, J. R., Davis-Poynter, N. J., Farrell, H. E.
(2009). The M33 Chemokine Receptor Homolog of Murine Cytomegalovirus Exhibits a Differential Tissue-Specific Role during In Vivo Replication and Latency. J. Virol.
83: 7590-7601
[Abstract]
[Full Text]
-
Stropes, M. P. M., Miller, W. E.
(2008). Functional analysis of human cytomegalovirus pUS28 mutants in infected cells. J. Gen. Virol.
89: 97-105
[Abstract]
[Full Text]
-
Bolovan-Fritts, C. A., Spector, S. A.
(2008). Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood
111: 175-182
[Abstract]
[Full Text]
-
Tadagaki, K., Yamanishi, K., Mori, Y.
(2007). Reciprocal roles of cellular chemokine receptors and human herpesvirus 7-encoded chemokine receptors, U12 and U51. J. Gen. Virol.
88: 1423-1428
[Abstract]
[Full Text]
-
Zhen, Z., Bradel-Tretheway, B., Sumagin, S., Bidlack, J. M., Dewhurst, S.
(2005). The Human Herpesvirus 6 G Protein-Coupled Receptor Homolog U51 Positively Regulates Virus Replication and Enhances Cell-Cell Fusion In Vitro. J. Virol.
79: 11914-11924
[Abstract]
[Full Text]
-
Casarosa, P., Waldhoer, M., LiWang, P. J., Vischer, H. F., Kledal, T., Timmerman, H., Schwartz, T. W., Smit, M. J., Leurs, R.
(2005). CC and CX3C Chemokines Differentially Interact with the N Terminus of the Human Cytomegalovirus-encoded US28 Receptor. J. Biol. Chem.
280: 3275-3285
[Abstract]
[Full Text]
-
Varani, S., Frascaroli, G., Homman-Loudiyi, M., Feld, S., Landini, M. P., Soderberg-Naucler, C.
(2005). Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J. Leukoc. Biol.
77: 219-228
[Abstract]
[Full Text]
-
Paulsen, S. J., Rosenkilde, M. M., Eugen-Olsen, J., Kledal, T. N.
(2005). Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor. J. Virol.
79: 536-546
[Abstract]
[Full Text]
-
Bolovan-Fritts, C. A., Trout, R. N., Spector, S. A.
(2004). Human Cytomegalovirus-Specific CD4+-T-Cell Cytokine Response Induces Fractalkine in Endothelial Cells. J. Virol.
78: 13173-13181
[Abstract]
[Full Text]
-
Hertel, L., Mocarski, E. S.
(2004). Global Analysis of Host Cell Gene Expression Late during Cytomegalovirus Infection Reveals Extensive Dysregulation of Cell Cycle Gene Expression and Induction of Pseudomitosis Independent of US28 Function. J. Virol.
78: 11988-12011
[Abstract]
[Full Text]
-
McGregor, A., Liu, F., Schleiss, M. R.
(2004). Molecular, Biological, and In Vivo Characterization of the Guinea Pig Cytomegalovirus (CMV) Homologs of the Human CMV Matrix Proteins pp71 (UL82) and pp65 (UL83). J. Virol.
78: 9872-9889
[Abstract]
[Full Text]
-
Penfold, M. E. T., Schmidt, T. L., Dairaghi, D. J., Barry, P. A., Schall, T. J.
(2003). Characterization of the Rhesus Cytomegalovirus US28 Locus. J. Virol.
77: 10404-10413
[Abstract]
[Full Text]
-
Minisini, R., Tulone, C., Luske, A., Michel, D., Mertens, T., Gierschik, P., Moepps, B.
(2003). Constitutive Inositol Phosphate Formation in Cytomegalovirus-Infected Human Fibroblasts Is due to Expression of the Chemokine Receptor Homologue pUS28. J. Virol.
77: 4489-4501
[Abstract]
[Full Text]
-
Casarosa, P., Menge, W. M., Minisini, R., Otto, C., van Heteren, J., Jongejan, A., Timmerman, H., Moepps, B., Kirchhoff, F., Mertens, T., Smit, M. J., Leurs, R.
(2003). Identification of the First Nonpeptidergic Inverse Agonist for a Constitutively Active Viral-encoded G Protein-coupled Receptor. J. Biol. Chem.
278: 5172-5178
[Abstract]
[Full Text]
-
Waldhoer, M., Kledal, T. N., Farrell, H., Schwartz, T. W.
(2002). Murine Cytomegalovirus (CMV) M33 and Human CMV US28 Receptors Exhibit Similar Constitutive Signaling Activities. J. Virol.
76: 8161-8168
[Abstract]
[Full Text]
-
Yu, D., Smith, G. A., Enquist, L. W., Shenk, T.
(2002). Construction of a Self-Excisable Bacterial Artificial Chromosome Containing the Human Cytomegalovirus Genome and Mutagenesis of the Diploid TRL/IRL13 Gene. J. Virol.
76: 2316-2328
[Abstract]
[Full Text]
-
Fraile-Ramos, A., Kledal, T. N., Pelchen-Matthews, A., Bowers, K., Schwartz, T. W., Marsh, M.
(2001). The Human Cytomegalovirus US28 Protein Is Located in Endocytic Vesicles and Undergoes Constitutive Endocytosis and Recycling. Mol. Biol. Cell
12: 1737-1749
[Abstract]
[Full Text]
-
Marschall, M., Freitag, M., Weiler, S., Sorg, G., Stamminger, T.
(2000). Recombinant Green Fluorescent Protein-Expressing Human Cytomegalovirus as a Tool for Screening Antiviral Agents. Antimicrob. Agents Chemother.
44: 1588-1597
[Abstract]
[Full Text]
-
Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A.
(2000). International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. Pharmacol. Rev.
52: 145-176
[Abstract]
[Full Text]
-
Penfold, M. E. T., Dairaghi, D. J., Duke, G. M., Saederup, N., Mocarski, E. S., Kemble, G. W., Schall, T. J.
(1999). Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. USA
96: 9839-9844
[Abstract]
[Full Text]
-
Hunninghake, G. W., Monick, M. M., Geist, L. J.
(1999). Cytomegalovirus Infection . Regulation of Inflammation. Am. J. Respir. Cell Mol. Bio.
21: 150-152
[Full Text]
-
Iwata, M., Vieira, J., Byrne, M., Horton, H., Torok-Storb, B.
(1999). Interleukin-1 (IL-1) Inhibits Growth of Cytomegalovirus in Human Marrow Stromal Cells: Inhibition Is Reversed Upon Removal of IL-1. Blood
94: 572-578
[Abstract]
[Full Text]
-
Chambers, J., Angulo, A., Amaratunga, D., Guo, H., Jiang, Y., Wan, J. S., Bittner, A., Frueh, K., Jackson, M. R., Peterson, P. A., Erlander, M. G., Ghazal, P.
(1999). DNA Microarrays of the Complex Human Cytomegalovirus Genome: Profiling Kinetic Class with Drug Sensitivity of Viral Gene Expression. J. Virol.
73: 5757-5766
[Abstract]
[Full Text]
-
Kirshner, J. R., Staskus, K., Haase, A., Lagunoff, M., Ganem, D.
(1999). Expression of the Open Reading Frame 74 (G-Protein-Coupled Receptor) Gene of Kaposi's Sarcoma (KS)-Associated Herpesvirus: Implications for KS Pathogenesis. J. Virol.
73: 6006-6014
[Abstract]
[Full Text]
-
Jarvis, M. A., Wang, C. E., Meyers, H. L., Smith, P. P., Corless, C. L., Henderson, G. J., Vieira, J., Britt, W. J., Nelson, J. A.
(1999). Human Cytomegalovirus Infection of Caco-2 Cells Occurs at the Basolateral Membrane and Is Differentiation State Dependent. J. Virol.
73: 4552-4560
[Abstract]
[Full Text]
-
MacDonald, M. R., Burney, M. W., Resnick, S. B., Virgin, H. W. IV
(1999). Spliced mRNA Encoding the Murine Cytomegalovirus Chemokine Homolog Predicts a beta Chemokine of Novel Structure. J. Virol.
73: 3682-3691
[Abstract]
[Full Text]
-
Casarosa, P., Bakker, R. A., Verzijl, D., Navis, M., Timmerman, H., Leurs, R., Smit, M. J.
(2001). Constitutive Signaling of the Human Cytomegalovirus-encoded Chemokine Receptor US28. J. Biol. Chem.
276: 1133-1137
[Abstract]
[Full Text]